说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 宫颈癌Ⅱb期
1)  cervical carcinoma/Ⅱb stage
宫颈癌Ⅱb期
2)  Early stage cervical carcinoma
早期宫颈癌
1.
Comparative analysis on laparoscopic and laparotomic surgery in treating early stage cervical carcinoma;
早期宫颈癌腹腔镜与开腹手术的临床比较分析
3)  advanced cervical cancer
晚期宫颈癌
1.
Randomized clinical trial of radiotherapy combined with chemotherapy of advanced cervical cancer.;
放、化疗联合治疗晚期宫颈癌的临床研究
2.
Objective To observe the effect of combination of DDP with radiotherapy in treating the patients with advanced cervical cancer.
观察顺铂和放疗在治疗晚期宫颈癌中的作用。
4)  Early cervical cancer
早期宫颈癌
1.
Objective:To compare laparoscopic and abdominal radical hysterectomy for the treatment of early cervical cancer.
目的:比较经腹腔镜与经腹根治性子宫切除治疗早期宫颈癌的临床。
5)  advanced cervical cancer
中晚期宫颈癌
1.
Clinical analysis of taxol plus cisplatin concurrent with radiotherapy for middle and advanced cervical cancer;
同步放化疗治疗中晚期宫颈癌的临床研究
2.
Clinical analysis of concurrent chemotherapy plus radiotherapy for advanced cervical cancer
同步放化疗治疗中晚期宫颈癌的疗效分析
3.
AIM: To analyze the changing of HPV DNA in cervical secretions and serum TNF-α level in patients with advanced cervical cancer before and after concurrent chemoradiotherapy.
目的:观察中晚期宫颈癌患者同步放化疗治疗前、后宫颈分泌物HPV DNA及血清TNF-α含量的变化趋势。
6)  locally advanced cervical cancer
局部晚期宫颈癌
1.
Relationship between ERCC1,XPC proteins and curative effect of neoadjuvant chemotherapy in locally advanced cervical cancers;
局部晚期宫颈癌细胞中XPC、ERCC1的表达与新辅助化疗疗效的关系
2.
To study the correlation of the expression of Bax protein before and after neoadjuvant chemotherapy with clinical effect, the expression of Bax protein was evaluated in tumor samples by immunohistochemistry in 23 patients with locally advanced cervical cancer before and after neoadjuvant intraarterial chemotherapy.
探讨Bax蛋白与宫颈癌新辅助化疗疗效之间的关系,用免疫组化方法检测23例局部晚期宫颈癌组织新辅助化疗前后Bax蛋白的表达。
3.
Objective To evaluate clinical effects of neoadjuvant intra-arterial chemotherapy for locally advanced cervical cancer.
方法选择2000年2月至2003年2月在本院确诊为局部晚期宫颈癌Ⅰb_2~Ⅱb期,并符合经动脉新辅助化疗+手术治疗适应证的患者86例为研究对象。
补充资料:宫颈复发癌


宫颈复发癌


多发生于晚期宫颈癌(包括局部晚期)治疗后,也有报告浸润性宫颈癌治疗后约有35%复发。复发性宫颈癌的治疗困难,预后差,是宫颈癌死亡最重要的原因。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条